S&P 5007,340.63-1.02%
Dow Jones50,759.42-1.64%
Nasdaq24,329.09-0.74%
FTSE 10010,697.29-1.69%
DAX26,118.00-1.49%
Nikkei 22558,860.43-1.34%
Gold3,853.20+0.01%
Crude Oil85.61-0.13%
Bitcoin64,248.12-0.90%
Ethereum1,804.03-0.83%
EUR / USD1.1000+0.02%
GBP / USD1.3207+0.17%
Insight Analytics
Insight Analytics
Visit Insight →
TTD
Beat
Q3 FY2026

The Trade Desk Q3 beats estimates but revenue slips year-over-year

Revenue of $736M topped consensus by 13%, but fell 0.5% from Q3 2025 as restructuring and investment costs weighed on earnings.

By Insight AnalyticsPublished Nov 9, 2026 · 2 min readSource: SEC 8-K Item 2.02 · About our coverage
The Trade Desk’s Q3 revenue of $736 million beat estimates by 13% but slipped 0.5% year-over-year, reflecting the tension between a headline beat and a step back.
The Trade Desk’s Q3 revenue of $736 million beat estimates by 13% but slipped 0.5% year-over-year, reflecting the tension between a headline beat and a step back.Photo by Negative Space on Pexels

The Trade Desk (NASDAQ: TTD) delivered a quarter that was simultaneously a beat and a step back. Revenue of $736 million topped analyst estimates of $651 million by 13%, yet slipped 0.5% from $739 million a year ago. Non-GAAP diluted EPS of $0.33 trounced the $0.04 consensus but fell from $0.45 in Q3 2025. The gap between the headline beat and the year-over-year decline is the quarter's defining tension.

CEO Jeff Green acknowledged the mixed picture, noting results were "well ahead of our expectations entering the quarter" but that the company is "still operating below the level of growth we expect from ourselves." That is not boilerplate. The Trade Desk is investing aggressively to reposition for durable growth, and Q3 shows the cost of that bet.

The GAAP numbers tell a harsher story. Net income fell to $38 million from $116 million, and GAAP diluted EPS dropped to $0.08 from $0.23. The culprit is a $44 million restructuring charge tied to the company's 2026 Restructuring Plan, which primarily covers severance and termination benefits. Add in higher stock-based compensation and increased platform costs, and the bottom line took a real hit.

Adjusted EBITDA margin compressed to 36% from 43% a year ago, producing $266 million of Adjusted EBITDA versus $317 million. The margin erosion is not cyclical; it reflects deliberate spending on technology and sales infrastructure. The company is ramping investment in its Kokai platform, agentic AI capabilities, and new measurement partnerships. That is a structural choice, not a demand problem.

Strategic wins in connected TV and healthcare provide the growth narrative. Netflix expanded its integration with The Trade Desk, allowing advertisers to use first- and third-party data to target audiences on Netflix through Kokai starting in November. New healthcare measurement partnerships with Veeva Crossix and IQVIA Digital give pharmaceutical advertisers real-time campaign insights. These are high-value verticals that could drive durable revenue growth if execution holds.

The board's capital allocation move is the strongest signal of confidence in the quarter. It expanded the share repurchase program by $731 million, bringing total authorization to $1 billion. The company had $269 million remaining as of September 30, so the new authorization is substantial. Buybacks at a $7.1 billion market cap suggest management sees the stock as undervalued relative to the long-term opportunity.

Q4 guidance calls for revenue of at least $755 million and Adjusted EBITDA of at least $280 million. That implies sequential revenue growth of roughly 2.6% from Q3's $736 million and an Adjusted EBITDA margin around 37%, a modest recovery from Q3's 36%. The guidance is achievable but not aggressive. Management is signaling caution rather than raising expectations despite the Q3 beat.

The Trade Desk is in a transition period. It is spending to build a stronger platform for the next phase of growth, but the current quarter shows the cost of that investment in real margin compression and lower earnings. The Q4 guide suggests a rebound is coming, but the pace of that recovery will determine whether the stock's current valuation is justified. Investors should watch whether the Netflix and healthcare partnerships translate into accelerating revenue growth in 2027.

Coverage of The Trade Desk, Inc. (TTD) Q3 FY2026. Insight News is a publication of Insight Analytics. Coverage is informational, not investment advice.

Generated by AI from the SEC filing linked in the sidebar. Numbers and quotes are drawn directly from the source document. Spot an error? support@insightanalytics.io.